1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ORAMED PHARMACEUTICALS, INC

Oramed Pharmaceuticals, Inc

XNAS: ORMP

Download real time

2.34 0.01 (0.43%)

25.48% Fall from 52W High

18,307 XNAS Volume

XNAS 24 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
11S
8W
6O
0T
94.3

Market Cap

Below industry Median
21.1

PE TTM

High in industry
0.2

PEG TTM

PEG TTM is less than 1
0.6

Price to Book

Below industry Median
0.1

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Oramed Pharmaceuticals, Inc is on 27 Mar 2025 for the purpose of Oramed Pharmaceuticals Inc Annual Report for 2024 See details
generated report

Analyze undervaluation/ overvaluation of Oramed Pharmaceuticals, Inc with historical PE and PBV ratios

Restated P/E Analysis

from 25 Mar, 2023

to 24 Mar, 2025

Sell Zone

78.7%     into P/E buy sell zone

Strong upside potential
% time spent below current P/E
Gains already realized

Out of 254 days, Oramed Pharmaceuticals, Inc traded 200 (78.7%) days below the current P/E of on Restated basis.

Originally Reported P/E Analysis

from 25 Mar, 2023

to 24 Mar, 2025

Sell Zone

78.7%     into P/E buy sell zone

Strong upside potential
% time spent below current P/E
Gains already realized

Out of 254 days, Oramed Pharmaceuticals, Inc traded 200 (78.7%) days below the current P/E of on Originally Reported basis.

Note: This is a reverse percentile score. Values close to 100% are bad while values close to 0% are good. Days when PE is negative are not considered in the analysis
↓
78.7 %

% Days traded below current P/E

Sell Zone

21.1

Current P/E

 
13.8

Average P/E

 
16.7

Median P/E

 
23.7

Highest P/E

 
4.3

Lowest P/E

 
P/E range Days traded in range % Days traded in range Days traded within & below range % Days traded within & below range
4-5
 60 23.6% 60 23.6%
5-10
 63 24.8% 123 48.4%
10-17
 9 3.5% 132 52.0%
17-20
 33 13.0% 165 65.0%
20-22
Current P/E is 21.1 		70 27.6% 235 92.5%
22-24
 19 7.5% 254 100.0%
Total 254 254
↓
78.7 %

% Days traded below current P/E

Sell Zone

21.1

Current P/E

 
13.8

Average P/E

 
16.9

Median P/E

 
23.7

Highest P/E

 
4.3

Lowest P/E

 
P/E range Days traded in range % Days traded in range Days traded within & below range % Days traded within & below range
4-5
 60 23.6% 60 23.6%
5-10
 63 24.8% 123 48.4%
10-17
 6 2.4% 129 50.8%
17-21
 64 25.2% 193 76.0%
21-22
Current P/E is 21.1 		42 16.5% 235 92.5%
22-24
 19 7.5% 254 100.0%
Total 254 254

FAQ

  • What is the PE ratio?

    In its simplest definition, the price-to-earnings ratio (P/E ratio) represents the price an investor pays per dollar of a company's earnings.
    For example, if a company has a P/E ratio of 25, investors are willing to pay USD 25 for each dollar of the company's current earnings. This indicates that investors value the stock at 25 times its current earnings, with an expectation of future earnings growth.
    The P/E ratio fluctuates based on investor sentiment towards a company. Positive sentiment drives the stock price higher, resulting in a higher P/E ratio (investors pay more for each dollar of earnings). Conversely, negative sentiment lowers the P/E ratio (investors pay less for each dollar of earnings).

  • What is the PE buy/sell zone?

    The PE buy/sell zone is calculated based on how many days a stock has traded at its current PE level.
    To do this, we compare the current PE to the stock’s historical PE performance, to find out how often (for how many days in the past) the stock has traded at its current PE value.
    If the stock has usually traded above its current PE level (it’s at a higher PE for the majority of trading days), then the stock is cheaper than usual and in the PE buy zone.
    If the stock has usually traded below its current PE level (it’s at a lower PE for the majority of trading days), then the stock is more expensive than usual and in the PE sell zone.

  • How is the PE buy sell zone useful?

    The PE buy sell zone tells you if a stock’s current PE level is unusually high or low, and if a stock doesn’t typically trade at that level. It helps investors identify stocks that are undervalued or overvalued in terms of their typical PE trading behavior.
    Investors should keep in mind that the buy zone/sell zone is not a foolproof buy or sell signal. For example, the PE of a stock may have fallen substantially due to adverse events or negative news. Or the PE may have risen sharply after the company has won new orders, made an acquisition, announced a buyback, or some other positive event. PE Buy/Sell Zone signals should be looked at in conjunction with other information.

  • Why are the number of days different for Restated and Originally Reported data?

    This can be because of any of the 2 following reasons:
    1. Days when PE is negative are not considered in the analysis. So if only 1 of the Restated or Originally Reported PE is negative and the other is not, then the days will be different
    2. Companies have reported Originally Reported data for limited period.
Buy Sell Stock Screeners